Hans-Peter Haring

Learn More
The ENDOSTROKE registry aims to accompany the spreading use of endovascular stroke treatment (EVT) in academic and non-academic hospitals. This analysis focuses on preprocedural imaging, patient handling and referral, as well as on different treatment modalities in mechanical recanalization. Data for this study were from observational registry study in 12(More)
OBJECTIVE A study was undertaken to evaluate clinical and procedural factors associated with outcome and recanalization in endovascular stroke treatment (EVT) of basilar artery (BA) occlusion. METHODS ENDOSTROKE is an investigator-initiated multicenter registry for patients undergoing EVT. This analysis includes 148 consecutive patients with BA occlusion,(More)
BACKGROUND Clinical outcome after endovascular stroke therapy (EVT) for proximal anterior circulation stroke is often disappointing despite high recanalization rates. The ENDOSTROKE study aims to determine predictors of clinical outcome in patients undergoing EVT. Here we focus on the impact of age and recanalization on proximal middle cerebral artery(More)
BACKGROUND AND PURPOSE We report the first case of 2 intravenous thrombolysis treatments within 90 hours in a patient with early recurrent stroke. SUMMARY OF REVIEW A 50-year-old man had improved significantly after intravenous thrombolysis for acute stroke. On the fourth day, he deteriorated dramatically because of recurrent stroke. Evidence of vessel(More)
The concept of vascular dementia is undergoing revision. The multi-infarct model and the Alzheimer's model of dementia, usually referred to as 'multi-infarct dementia', are gradually being replaced by a much broader concept of vascular cognitive impairment. This conceptual evolution reflects a more profound understanding of the pathogenic mechanisms that(More)
We read with interest the article by Fries and Krishnan about equipoise, design bias and randomized controlled trials [1]. It is important to stress that equipoise is not the principle underlying company-driven clinical trials, which are doubtlessly necessary and useful for medical progress. As a rule, companies’ clinical research departments cannot afford(More)
The objective of this study was to analyse the Neurothrombectomy Network registry of the Neuromed Campus (NMC) of the Kepler University Hospital in Linz (Austria). The data were compared to the results of recently published thrombectomy trials (MR CLEAN, ESCAPE, EXTEND-IA, SWIFT-PRIME, REVASCAT and THRACE). We retrospectively studied 246 patients with acute(More)
Admission C-Reactive Protein as a Predictor for Stroke Outcome Among Candidates for Thrombolysis: Decision Adjourned To the Editor: We read with interest the article by Montaner et al1 in which the authors claim that poststroke C-reactive protein (CRP) is a powerful prognostic tool among candidates for intravenous thrombolysis. The study raises several(More)